Rep. Grothman Introduces Bill to Increase Insulin Competition and Affordability
September 10, 2020
September 10, 2020
WASHINGTON, Sept. 10 -- Rep. Glenn Grothman, R-Wisconsin, issued the following news release:
Congressmen Glenn Grothman (WI-06) introduced legislation to help increase competition in the insulin market, expand availability to affordable insulin products and lower costs to patients who depend on insulin.
The Biosimilar Insulin Access Act will waive interchangeability requirements for insulin products granted biosimilar approval by the Food and Drug Administration (FDA). . . .
Congressmen Glenn Grothman (WI-06) introduced legislation to help increase competition in the insulin market, expand availability to affordable insulin products and lower costs to patients who depend on insulin.
The Biosimilar Insulin Access Act will waive interchangeability requirements for insulin products granted biosimilar approval by the Food and Drug Administration (FDA). . . .